Corteva sees $1B in incremental sales through 2027, unveils non-GMO wheat 'breakthrough'

seekingalpha
20 Nov 2024

jetcityimage/iStock Editorial via Getty Images

Corteva (NYSE:CTVA) +1.7% in Tuesday's trading after saying said it is targeting $1B in incremental sales from growth platforms, as part of its new financial framework through 2027, and announcing a newly authorized $3B stock buyback program.

The company said it anticipates $1B

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10